Form 8-K - Current report:
SEC Accession No. 0001558370-24-014768
Filing Date
2024-11-07
Accepted
2024-11-07 08:38:00
Documents
54
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apre-20241107x8k.htm   iXBRL 8-K 41705
2 EX-99.1 apre-20241107xex99d1.htm EX-99.1 152054
3 EX-99.2 apre-20241107xex99d2.htm EX-99.2 59209
4 GRAPHIC apre-20241107xex99d2g001.jpg GRAPHIC 98801
5 GRAPHIC apre-20241107xex99d2g002.jpg GRAPHIC 313310
6 GRAPHIC apre-20241107xex99d2g003.jpg GRAPHIC 177675
7 GRAPHIC apre-20241107xex99d2g004.jpg GRAPHIC 117521
8 GRAPHIC apre-20241107xex99d2g005.jpg GRAPHIC 133606
9 GRAPHIC apre-20241107xex99d2g006.jpg GRAPHIC 170127
10 GRAPHIC apre-20241107xex99d2g007.jpg GRAPHIC 57333
11 GRAPHIC apre-20241107xex99d2g008.jpg GRAPHIC 208985
12 GRAPHIC apre-20241107xex99d2g009.jpg GRAPHIC 73972
13 GRAPHIC apre-20241107xex99d2g010.jpg GRAPHIC 144563
14 GRAPHIC apre-20241107xex99d2g011.jpg GRAPHIC 213708
15 GRAPHIC apre-20241107xex99d2g012.jpg GRAPHIC 153534
16 GRAPHIC apre-20241107xex99d2g013.jpg GRAPHIC 132941
17 GRAPHIC apre-20241107xex99d2g014.jpg GRAPHIC 131641
18 GRAPHIC apre-20241107xex99d2g015.jpg GRAPHIC 82211
19 GRAPHIC apre-20241107xex99d2g016.jpg GRAPHIC 112412
20 GRAPHIC apre-20241107xex99d2g017.jpg GRAPHIC 56537
21 GRAPHIC apre-20241107xex99d2g018.jpg GRAPHIC 149366
22 GRAPHIC apre-20241107xex99d2g019.jpg GRAPHIC 139692
23 GRAPHIC apre-20241107xex99d2g020.jpg GRAPHIC 97141
24 GRAPHIC apre-20241107xex99d2g021.jpg GRAPHIC 135186
25 GRAPHIC apre-20241107xex99d2g022.jpg GRAPHIC 58325
26 GRAPHIC apre-20241107xex99d2g023.jpg GRAPHIC 130711
27 GRAPHIC apre-20241107xex99d2g024.jpg GRAPHIC 178053
28 GRAPHIC apre-20241107xex99d2g025.jpg GRAPHIC 128710
29 GRAPHIC apre-20241107xex99d2g026.jpg GRAPHIC 169758
30 GRAPHIC apre-20241107xex99d2g027.jpg GRAPHIC 53806
31 GRAPHIC apre-20241107xex99d2g028.jpg GRAPHIC 165941
32 GRAPHIC apre-20241107xex99d2g029.jpg GRAPHIC 114765
33 GRAPHIC apre-20241107xex99d2g030.jpg GRAPHIC 152669
34 GRAPHIC apre-20241107xex99d2g031.jpg GRAPHIC 130428
35 GRAPHIC apre-20241107xex99d2g032.jpg GRAPHIC 128526
36 GRAPHIC apre-20241107xex99d2g033.jpg GRAPHIC 128315
37 GRAPHIC apre-20241107xex99d2g034.jpg GRAPHIC 78355
38 GRAPHIC apre-20241107xex99d2g035.jpg GRAPHIC 162869
39 GRAPHIC apre-20241107xex99d2g036.jpg GRAPHIC 139944
40 GRAPHIC apre-20241107xex99d2g037.jpg GRAPHIC 148706
  Complete submission text file 0001558370-24-014768.txt   7219849

Data Files

Seq Description Document Type Size
41 EX-101.SCH apre-20241107.xsd EX-101.SCH 4369
42 EX-101.DEF apre-20241107_def.xml EX-101.DEF 2847
43 EX-101.LAB apre-20241107_lab.xml EX-101.LAB 12248
44 EX-101.PRE apre-20241107_pre.xml EX-101.PRE 11774
56 EXTRACTED XBRL INSTANCE DOCUMENT apre-20241107x8k_htm.xml XML 4859
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 241433382
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)